by Helen Dunne on 07/04/2009 16:58:00 in CorpComms Online | share me: del.icio.us | digg | reddit | Tweet
Brunswick's standing boosted by healthcare deals

Helen Dunne is the editor of CorpComms Magazine, follow her tweets here @CorpCommsMag

Winning the mandate to advise Pfizer on its $64 billion (£43 billion) acquisition of Wyeth and Roche on its $47 billion (£31 billion) purchase of a 44 per cent stake in Genentech pushed Brunswick to the top of the M&A PR advisers' league table during the first quarter.
Brunswick offered PR advice on 27 deals with a total value of $137 billion (£92 billion) in the first three months, according to mergermarket. It also topped the European and North America league tables.
Almost 1,700 deals with a value of $409 billion were announced in the first quarter. It was the worst quarter by value since the third quarter of 2004, when deals worth $343 billion were announced, and the worst first quarter in six years - by both volume and value.
The top three deals in North America were also the top three deals globally, and account for $154 billion (or 38 per cent) of the total value of M&A activity.
Sard Verbinnen and Kekst took the second and third positions in the global league table, advising on deals worth $83 billion and $63 billion respectively. Both were involved in the top
Finsbury took fourth place, advising on 14 deals (including three of the top ten) worth $49.5 billion, while FD came in sixth with 21 deals worth $19.6 billion.
share me: del.icio.us | digg | reddit | Tweet